POINT Biopharma Global Inc.
PNTNASDAQHealthcare
$12.50
+$0.02(+0.16%)
Market Cap$1.3B
P/E Ratio—
52W High$14.35
52W Low$6.57
POINT Biopharma Global Inc.（PNT）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · PNT · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $0.23B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.23B | $0.00B | $0.00B | $0.00B |
| Gross Margin %(computed) | 100.00% | — | — | — |
| Operating Expenses | ||||
| R&D Expenses | $0.08B | $0.03B | $0.01B | $0.00B |
| G&A Expenses | $0.02B | $0.01B | $0.00B | $0.00B |
| Total Operating Expenses | $0.10B | $0.05B | $0.01B | $0.00B |
| Operating Income | $0.13B | ($0.05B) | ($0.01B) | ($0.00B) |
| Operating Margin %(computed) | 55.40% | — | — | — |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.13B | ($0.05B) | ($0.01B) | ($0.00B) |
| Income Tax Expense | $0.03B | $0.00B | $0.00B | $0.00B |
| Net Income | $0.10B | ($0.05B) | ($0.01B) | ($0.00B) |
| Net Margin %(computed) | 43.38% | — | — | — |
| Per Share & EBITDA | ||||
| EPS (Basic) | $1.04 | $-0.62 | $-0.34 | $0.00 |
| Wtd Avg Shares | 0.09B | 0.07B | 0.04B | 0.00B |
| EBITDA | $0.13B | ($0.05B) | ($0.01B) | ($0.00B) |
| EBITDA Margin %(computed) | 56.19% | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · B
深入了解POINT Biopharma Global Inc.
关于POINT Biopharma Global Inc.（PNT）损益表
POINT Biopharma Global Inc.（PNT）损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年，PNT实现营收$0.23B，毛利润$0.23B（毛利率100.00%），净利润$0.10B（净利率43.38%）。
常见问题
PNT · 4 问POINT Biopharma Global Inc.（PNT）2022财年营收为$0.23B，同比up—%。
PNT revenuePNT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09